読み込み中
Filana Therapeutics, Inc. is a company dedicated to pioneering new pharmaceutical products and diagnostic technologies. A key area of its research is focused on creating potential treatments for Alzheimer's disease, including the investigational compounds PTI-125 and PTI-125Dx. Established by Remi Barbier in May 1998, the firm maintains its principal office in Austin, Texas.
前日終値
$0.8168
+$0.0032 · +0.39%
日中の時刻はETです。市場データは遅延する場合があります。
Filana Therapeutics, Inc. is a company dedicated to pioneering new pharmaceutical products and diagnostic technologies. A key area of its research is focused on creating potential treatments for Alzheimer's disease, including the investigational compounds PTI-125 and PTI-125Dx. Established by Remi Barbier in May 1998, the firm maintains its principal office in Austin, Texas.
日中レンジ
現在 $0.8168
52週レンジ
現在 $0.8168
日中の時刻はETです。市場データは遅延する場合があります。
Filana Therapeutics, Inc. is a company dedicated to pioneering new pharmaceutical products and diagnostic technologies. A key area of its research is focused on creating potential treatments for Alzheimer's disease, including the investigational compounds PTI-125 and PTI-125Dx. Established by Remi Barbier in May 1998, the firm maintains its principal office in Austin, Texas.
日中レンジ
現在 $0.8168
52週レンジ
現在 $0.8168
直近の発表実績
| 種別 | 発効日 | 詳細 | 基準日 | 支払日 |
|---|---|---|---|---|
株式分割 | 2017年5月10日 | 1:7 | — | — |
発効済み 2017年5月10日
1:7
AIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。
